Potential antidiabetics. 11. Preparation of 4-arylazo-3,5-disubstituted-(2H)-1,2,6-thiadiazine 1,1-dioxides.
D000818:Animals; D001391:Azo Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D006571:Heterocyclic Compounds / Q000138:chemical synthesis*; D007004:Hypoglycemic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D007259:Infrared Rays; D051379:Mice; D013057:Spectrum Analysis; D013450:Sulfones / Q000138:chemical synthesis / Q000494:pharmacology; D013829:Thiadiazines / Q000138:chemical synthesis / Q000494:pharmacology
D001391:Azo Compounds; D001786:Blood Glucose; D006571:Heterocyclic Compounds; D007004:Hypoglycemic Agents; D013450:Sulfones; D013829:Thiadiazines